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Introduction
In Greece Klebsiella pneumoniae producing KPC-2 car-
bapenemase (Kp-KPC+) constitute an important public
health problem.
Objectives
To investigate the epidemiology of Kp-KPC+ isolates in
a secondary general hospital in Greece, with no prior
history of Kp-KPC+ until 2010.
Methods
>Between 2011 and 2014,156 Klebsiella pneumoniae
isolates were recorded from routine laboratory tests.
Carbapenemases production was tested by Modified
Hodge Test. Phenylboronic acid, EDTA or both along
with meropenem discs were used as inhibitors for detec-
tion of Klebsiella pneumoniae carbapenemases (KPCs),
metallo-beta lactamases (MBLs) or both carbapene-
mases, respectively. Susceptibility testing for various
antimicrobial agents including carbapenems was per-
formed by the disk diffusion method according to CLSI
criteria. MICs were determined by Vitek-2 or E-test
methodology. blaKPC, blaVIM and blaNDM genes were
detected by PCR. Clinical data, related to admission,
previous hospitalizations and outcome, were collected
using patients’ medical records.
Results
During the study period, 18 Klebsiella pneumoniae isolates
were found as KPC-2 producers (11,5%). No other carba-
penemase gene was detected in our hospital during the
study period. The majority of Kp-KPC(+) isolates were
recovered from urine cultures. All isolates were highly
resistant to carbapenems, whereas susceptibility rates for
colistin, tigecyclin and gentamicin were 100%, 92% and
77%, respectively. The first KPC-2 positive isolate was
detected in September 2011. The yearly distribution of
these patients was: 2011(3), 2012 (7), 2013 (4), 2014 (4). 10
patients had a history of previous hospitalization in tertiary
care hospitals in Athens. Crude mortality rate among
patients with Kp-KPC(+) was high (6/18, 33,3%). Coloniza-
tion/infection during hospitalization was not identified.
Conclusion
In our hospital there is a low prevalence of Kp-KPC+
compared to tertiary care hospitals in Athens. Given the
antimicrobial therapy toxicity, the prolongation of hospita-
lization and the mortality due to possible therapy failure,
special care should be taken.
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